tiprankstipranks
Trending News
More News >
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH

Aurinia Pharmaceuticals (AUPH) Revenue

Compare
2,027 Followers

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals had a revenue of 59.87M in the quarter ending Dec 31, 2024, with -11.66%. This bring the company's revenue in the last twelve months to 235.13M, Decreased 6.70%. In the fiscal year ending Dec 31, 2024, Aurinia Pharmaceuticals had annual revenue of 235.13M with 33.97% growth.
Revenue (ttm)
235.13M
Revenue Growth
33.97%
P/S Ratio
4.33
Revenue/Employee
$1,808,715
Employees
130
Market Cap
$1.02B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024235.13M59.62M+33.97%
Dec 31, 2023175.51M41.48M+30.95%
Dec 31, 2022134.03M88.42M+193.89%
Dec 31, 202145.60M-4.51M-9.00%
Dec 31, 202050.12M49.80M+15,660.38%
Dec 31, 2019318.00K-145.00K-31.32%
Dec 31, 2018463.00K43.00K+10.24%
Dec 31, 2017420.00K247.00K+142.77%
Dec 31, 2016173.00K-62.00K-26.38%
Dec 31, 2015235.00K-43.00K-15.47%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis